Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Progress toward treatments for synaptic defects in autism.

Delorme R, Ey E, Toro R, Leboyer M, Gillberg C, Bourgeron T.

Nat Med. 2013 Jun;19(6):685-94. doi: 10.1038/nm.3193. Epub 2013 Jun 6. Review.

PMID:
23744158
2.

Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders.

Santini E, Klann E.

Sci Signal. 2014 Oct 28;7(349):re10. doi: 10.1126/scisignal.2005832. Review.

PMID:
25351249
3.

The genetic landscapes of autism spectrum disorders.

Huguet G, Ey E, Bourgeron T.

Annu Rev Genomics Hum Genet. 2013;14:191-213. doi: 10.1146/annurev-genom-091212-153431. Epub 2013 Jul 22. Review.

PMID:
23875794
4.

Therapeutic approaches for shankopathies.

Wang X, Bey AL, Chung L, Krystal AD, Jiang YH.

Dev Neurobiol. 2014 Feb;74(2):123-35. doi: 10.1002/dneu.22084. Epub 2013 Oct 11. Review.

5.

[Genetic analyses for identifying molecular mechanisms in autism spectrum disorders].

Chiocchetti A, Klauck SM.

Z Kinder Jugendpsychiatr Psychother. 2011 Mar;39(2):101-11. doi: 10.1024/1422-4917/a000096. Review. German.

PMID:
21442598
6.
7.

Key role for gene dosage and synaptic homeostasis in autism spectrum disorders.

Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, Fauchereau F, Coleman M, Leboyer M, Gillberg C, Bourgeron T.

Trends Genet. 2010 Aug;26(8):363-72. doi: 10.1016/j.tig.2010.05.007. Epub 2010 Jul 6. Review.

PMID:
20609491
8.

Ultrasonic vocalizations in Shank mouse models for autism spectrum disorders: detailed spectrographic analyses and developmental profiles.

Wöhr M.

Neurosci Biobehav Rev. 2014 Jun;43:199-212. doi: 10.1016/j.neubiorev.2014.03.021. Epub 2014 Apr 12. Review.

PMID:
24726578
9.

Communication, interventions, and scientific advances in autism: a commentary.

Llaneza DC, DeLuke SV, Batista M, Crawley JN, Christodulu KV, Frye CA.

Physiol Behav. 2010 Jun 1;100(3):268-76. doi: 10.1016/j.physbeh.2010.01.003. Epub 2010 Jan 21. Review.

10.

Brain mechanisms of plasticity in response to treatments for core deficits in autism.

Ventola PE, Oosting D, Anderson LC, Pelphrey KA.

Prog Brain Res. 2013;207:255-72. doi: 10.1016/B978-0-444-63327-9.00007-2. Review.

PMID:
24309258
11.

Novel treatments in autism spectrum disorders: from synaptic dysfunction to experimental therapeutics.

Canitano R.

Behav Brain Res. 2013 Aug 15;251:125-32. doi: 10.1016/j.bbr.2012.11.024. Epub 2012 Nov 29. Review.

PMID:
23202136
12.

The BTBR T+ tf/J mouse model for autism spectrum disorders-in search of biomarkers.

Meyza KZ, Defensor EB, Jensen AL, Corley MJ, Pearson BL, Pobbe RL, Bolivar VJ, Blanchard DC, Blanchard RJ.

Behav Brain Res. 2013 Aug 15;251:25-34. doi: 10.1016/j.bbr.2012.07.021. Epub 2012 Aug 9. Review.

13.

Repetitive behaviors in the Shank1 knockout mouse model for autism spectrum disorder: developmental aspects and effects of social context.

Sungur AÖ, Vörckel KJ, Schwarting RK, Wöhr M.

J Neurosci Methods. 2014 Aug 30;234:92-100. doi: 10.1016/j.jneumeth.2014.05.003. Epub 2014 May 9.

PMID:
24820912
14.

[Genetics and animal modeling of autism spectrum disorders. New developments].

Klauck SM, Poustka L, Chiocchetti A.

Nervenarzt. 2011 May;82(5):553-62. doi: 10.1007/s00115-010-3241-z. Review. German.

PMID:
21472451
15.

NMDA receptor dysfunction in autism spectrum disorders.

Lee EJ, Choi SY, Kim E.

Curr Opin Pharmacol. 2015 Feb;20:8-13. doi: 10.1016/j.coph.2014.10.007. Epub 2015 Jan 28. Review.

PMID:
25636159
16.

Behavioral profiles of mouse models for autism spectrum disorders.

Ey E, Leblond CS, Bourgeron T.

Autism Res. 2011 Feb;4(1):5-16. doi: 10.1002/aur.175. Epub 2011 Jan 5.

PMID:
21328568
17.

Mutant mouse models of autism spectrum disorders.

Provenzano G, Zunino G, Genovesi S, Sgadó P, Bozzi Y.

Dis Markers. 2012;33(5):225-39. doi: 10.3233/DMA-2012-0917. Review.

18.

A blueprint for research on Shankopathies: a view from research on autism spectrum disorder.

Carbonetto S.

Dev Neurobiol. 2014 Feb;74(2):85-112. doi: 10.1002/dneu.22150. Epub 2013 Dec 17. Review.

19.

Synaptic plasticity as a therapeutic target in the treatment of autism-related single-gene disorders.

Pignatelli M, Feligioni M, Piccinin S, Molinaro G, Nicoletti F, Nisticò R.

Curr Pharm Des. 2013;19(36):6480-90. Review.

PMID:
23432715
20.

Modeling of autism genetic variations in mice: focusing on synaptic and microcircuit dysfunctions.

Qiu S, Aldinger KA, Levitt P.

Dev Neurosci. 2012;34(2-3):88-100. Epub 2012 May 8. Review.

PMID:
22572629

Supplemental Content

Support Center